FBPixel Chemotherapy-driven dysbiosis in the intestinal microbiome - David Perlmutter M.D.

Science

Study Title
Chemotherapy-driven dysbiosis in the intestinal microbiome
Publication
Alimentary Pharmacology and Therapeutics
Author(s)

E. Montassier, T. Gastinne, P. Vangay, G. A. Al-Ghalith, S. Bruley des Varannes, S. Massart, P. Moreau, G. Potel, M. F. de La Cocheti ere, E. Batard & D. Knights

Abstract

To identify functional mechanisms by which the intestinal microbiome may play a key role in the pathophysiology of GI mucositis, we applied high- throughput DNA-sequencing analysis to identify microbes and microbial functions that are modulated following chemotherapy.

Date
July 6, 2015
View study

Share This

Related Topics

ChemotherapyFirmicutesDysbiosisMicrobiome

Dr. David Perlmutter is on the cutting edge of innovative medicine that looks at all lifestyle influences on health and illness.

Andrew Weil, MD